Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand (Q73035541)
Jump to navigation
Jump to search
scientific article published on 01 October 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand |
scientific article published on 01 October 2000 |
Statements
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand (English)
Bielekova B
Goodwin B
Richert N
Cortese I
Kondo T
Afshar G
Eaton J
Antel J
Frank JA
McFarland HF
1 October 2000